Skip to main navigation Skip to search Skip to main content

Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions (Clinical Reviews in Allergy & Immunology, (2020), 59, 2, (231-247), 10.1007/s12016-019-08775-4)

Research output: Contribution to journalComment/debate

Abstract

The original version of this article unfortunately contained a mistake in the fifth paragraph of the “Conclusion” section.

Original languageEnglish
Pages (from-to)273
Number of pages1
JournalClinical Reviews in Allergy and Immunology
Volume59
Issue number2
DOIs
StatePublished - Oct 1 2020

Fingerprint

Dive into the research topics of 'Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions (Clinical Reviews in Allergy & Immunology, (2020), 59, 2, (231-247), 10.1007/s12016-019-08775-4)'. Together they form a unique fingerprint.

Cite this